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A DEEP LEARNING APPROACH TO DETECT DIABETIC RETINOPATHY IN FUNDUS IMAGES 
Winston Furtado 
April 2019 
Background: Diabetic retinopathy is a disease caused due by complications of diabetes mellitus 
which can lead to blindness. About 33% of the US population with diabetes also show symptoms 
for diabetes retinopathy. If not treated, diabetic retinopathy worsens over time by progressing 
through two main pathological stages of non-proliferative and proliferative and four clinical 
stages. While the diagnostic accuracy of detecting diabetic retinopathy through machine learning 
have shown to be successful for OCT images, the accuracy of ultra-widefield fundus images 
have yet to be fully reported. This paper describes a method to non-invasively detect and 
diagnose diabetic retinopathy from ultra-widefield fundus images. 
 
Methods: A total of 62 graded-images were obtained from the Cleveland Clinic. A deep learning 
algorithm was developed to identify and extract features from the images. The algorithm was 
then simulated to classify the test images into one of three clinical classes. Data was collected on 
the accuracy and probability of the diagnosis/classification.  
 
Results: The classification algorithm had an average accuracy that ranged from 92% to 97% for 
the training images and 50% for the test images. Confusion matrices were created to obtain 
statistical measures of performance such as sensitivity, false negative rate, precision, and the 
false discovery rate. The sensitivity decreased from 70% to 50% as the image size increased. The 
precision also decreased from 65% to 50% as the image size increased. Validation methods such 
as image normalization and transfer learning showed no improvement in classification accuracy.  
 
Conclusion: This study demonstrates the potential for applying deep learning algorithms to 
classify ultra-widefield images. This study also demonstrates the need for doctors to further 
examine the diagnosis to account for false positives and/or misdiagnosis. Additionally, 
limitations and their impact on the simulation of the deep learning algorithm were explored. 
 
Keywords: diabetic retinopathy; deep learning; CNN; image classification; ultra-wide field imaging
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Diabetic retinopathy (DR) is the leading cause of blindness among adults in 
the United States. It is the result of diabetes mellitus which itself is a global epidemic 
leading to a range of complications [1]. The main risk factors associated with diabetic 
retinopathy are duration of the diabetes, high blood sugar levels, and arterial 
hypertension [2][3][4]. At the onset, it affects the blood vessels in the retina, a 
photosensitive tissue found at the back of the eye. Overtime, under high elevation of 
glucose, the blood vessels can cause capillary endothelial damage which results in the 
cells along the capillary to become “leaky”. The high glucose levels combined with 
endothelial damage lead to capillary occlusion which, in turn, leads to reduced blood 
flow [5]. If not treated, diabetic retinopathy progresses through four clinical stages 
(Figure 1) of  mild non-proliferative, moderate non-proliferative, severe non-
proliferative, which is sometimes subclassified into severe non-proliferative and very 
severe non-proliferative, and proliferative which is sometimes subclassified into non-
high risk proliferative, and high risk proliferative, and advanced proliferative. In each 
stage there are problems that can occur (shown in Figure 2): such as microaneurysms 
(mild, moderate, severe, and proliferative stages), hemorrhages (moderate, severe, and 
proliferative stages), exudates (moderate, severe and proliferative stages), cotton-wool 
spots (severe, pre-proliferative, and proliferative stages), and intraretinal 
microvascular anomalies (proliferative stage) [5]. Microaneurysms are one of the 
earliest signs of diabetic retinopathy; classified as mild non-proliferative. They appear 
as red dots in the retina due to an expansion of the capillaries. In small numbers, 
microaneurysms do not affect the eyesight of a patient. Regardless, the number of 
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microaneurysms can be used to estimate the regression or progression of diabetic 
retinopathy. Hemorrhages occur due to the rupture of small blood vessels in the retina, 
which results in red lesions. Hemorrhages occur deep in the retina where their shape is 
determined by their location or position. Even though hemorrhages are a cause of 
concern, they do not functionally disrupt the eye. Like microaneurysms, the number of 
hemorrhages can be used to estimate the progression or regression of diabetic 
retinopathy. Exudates define the yellow-white lesions that occur due to the leakage of 
plasma from capillaries near the macular region. Exudates away from the macular 
region have been observed but have not been found to cause serious problems. The 
first sighting of exudates means that diabetic retinopathy has progressed from the mild 
to the moderate non-proliferative stage. Cotton-wool spots are caused by failure of 
capillary circulation, which leads to the swelling of nerve fibers. They appear as pale 
or fuzzy areas on the retina. Solely, the cotton-wool spots do not cause visual 
problems, but their presence is graded as pre-proliferative or severe depending on how 
widespread they are. Intraretinal microvascular anomalies (IRMAs) or microvascular 
abnormalities represent the first sign of new blood vessels appearing. The cause of 
IRMAs is due to the dilation of capillaries and the shunts between the arteries and 
veins. Additionally, the retinal veins appear tortuous and irregular. Any patient with 
IRMAs is classified as proliferative, in which case they must seek medical help 
immediately. 
It is estimated that about 30% to 50% of the diabetic population has 
retinopathy. In longitudinal studies, about 30% of the affected individuals showed 
symptoms of diabetic retinopathy after 10 to 20 years of progression with diabetes 
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mellitus. Of the 30% affected, 10% progressed to proliferative retinopathy, which puts  
patients at risk of blindness. In 90% of the cases examined, non-proliferative 
retinopathy is responsible for a serious loss of visual capacity. Non-proliferative 
retinopathy is also observed to occur more often in cases where diabetes onset started 
in adulthood, whereas proliferative retinopathy is present “generally”, though not 
always in juvenile forms of the disease [5]. Another study, the classical Wisconsin 
Epidemiologic Study of Diabetic Retinopathy (WESDR), reported that about 75% of 
people diagnosed with diabetes mellitus showed signs and symptoms of diabetic 
retinopathy after 10 years. For those who developed early symptoms, about 66% of 
the people exhibited the severe stage of diabetic retinopathy. About 20% of those 
affected had the disease progress to proliferative diabetic retinopathy or diabetic 
macular odema, a subtype of diabetic retinopathy that involves the macula 
[2][3][6][7]. 
Before 1961, to detect diabetic retinopathy, various diagnostic techniques were 
utilized. A visual acuity test was used to detect how well a person could see at various 
distances. A dilated eye exam was done to closely examine the retina and optic nerve 
for signs of damage. Additionally, a tonometry was done to detect abnormal pressure 
(<12 mmHg or >22 mmHg) inside the eye [8]. With the advance of diagnostic 
medicine came the arrival of new imaging technologies. One such technology was 
fluorescein angiography. Fluorescein angiography involved using a fluorescent dye to 
mark the eye after which pictures were taken to identify vascular leakage and the 
presence of ischemia [9] [10]. Although traditionally used as the primary method in 
diagnosing diabetic retinopathy, fluorescein angiography was phased out over time in 
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  Figure 1 - Stages of diabetic retinopathy [31]. 
preference of optical coherence tomography (OCT). Optical coherence tomography 
was considered a major technical innovation that did not require the need for pupil 
dilation and could be adopted with telemedicine to offer fast, accurate, systematic 
solutions in both developed and developing countries. [11] [12] [13]. As a non-
invasive diagnostic technology, it creates high-resolution images of the retina to 
record 3D structural changes (e.g. odema) which otherwise cannot be deduced through 
a clinical examination of retinal pictures. At present, new fundus photography 
techniques are being tested and developed (e.g. wide-field fluorescein angiography) 
with some already introduced to the market, including the ultra-widefield (UWF) 
retinal imaging device, Optos 200 Tx, sold by Optos plc. Compared to current 
imaging techniques, ultra-widefield devices can image up to 200 degrees, thus 
providing more information to help clinicians accurately diagnose the condition. 

















Figure 2 – Representations of various types of damage to capillaries in DR. (a) 
normal capillary. (b) microaneurysm. (c) hemorrhage. (d) exudate [5]. 
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duplication and manipulation with ease [32]. 
With a recent rise in machine learning, applications in medical diagnostics 
have been explored due to their high classification accuracy. Deep learning, a subset 
of machine learning, uses multiple layers for feature extraction from an image. The 
input into each layer uses the output from the previous layer thus allowing every layer 
in the algorithm to independently learn the features. Deep learning models are 
typically trained using large datasets with an appropriate neural network to learn the 
features in an image without prior knowledge. The use of deep learning for medical 
images has been studied by LeCun et al. [14], Liu et al. [15], and Litjens et al. [16]. 
While most of the research on optical coherence tomography images has been 
explicitly based on segmenting features such as blood vessels and identifying the 
stage of diabetic retinopathy through a classifier, new research in the ophthalmologic 
field has been done by Pratt et al. [17], Sangeethaa et al. [18], and Chandrakumar [19] 
to detect diabetic retinopathy using the convoluted neural network (CNN). This 
network consists of three layers: input layer, hidden layer, and output layer. The 
hidden layer encompasses convolution and pooling layers to reduce computational 
time. As a part of deep learning, CNNs eliminate the need for manual feature 
extraction and can be retrained for new classification tasks. While the diagnostic 
accuracy of detecting diabetic retinopathy from OCT images has proven to be 
successful through CNN, the accuracy of ultra-widefield fundus images have yet to be 
fully investigated, especially involving various classes/stages. Therefore, the goals of 
this study are to develop and utilize CNN to help classify ultra-widefield fundus 
images into one of the 3 major classes of diabetic retinopathy; evaluate and compare 
7 
 
the accuracy of the classification between different areas and sizes of fundus images; 





2.1 Image Dataset  
The images for this research were received from the Cleveland Clinic. There 
was a total of 62 images sent, 26 TIF format and 36 JPEG format, each of which 
represented 62 patients. The images were taken by a technician on an ultra-wide field 
ophthalmoscope with the resulting dimensions of most images being 3900 × 3071 
(JPEG) and the remaining images being 3900 × 3072 (TIF). The horizontal and 
vertical resolution was 96 dpi (dots per inch). These images were then graded by an 
ophthalmologist and categorized into 1 of 7 classes based on the Early Treatment 
Diabetic Retinopathy Study (ETDRS) scale: mild (11 images), moderate (11 images), 
severe (15 images), very severe (14 images), non-high risk (4 images), high risk (3 
images), and advanced (4 images). 
 
2.2 Preparation and Pre-processing of Images 
Due to the small number of images and uneven classes, the fundus images 
were organized into three main classes: mild (mild + moderate images), severe (severe 
+ very severe images), and high risk (non-high risk + high risk + advanced images). 
This was done to balance the classes and provide enough training data for the machine 
learning algorithm. It is important to note that if there were “normal” images or 
images that showed no signs of diabetic retinopathy, then four classes would’ve been 
created to differentiate between normal, mild, severe, and high-risk diabetic 
retinopathy. Once the images were organized, using MATLAB, five masks at various 
diameters following a concentric pattern from the center of the fundus image were 
created. The masks were created to help isolate the region of interest (ROI) in the 
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fundus images. After the creation of the mask, desired images with the ROI were cut 
out and converted to TIF format to prepare for training through the CNN. To begin 
pre-processing, the desired image dimension (e.g. 32 × 32) was chosen for the input 
layer. Once the images were inputted, they were shuffled to make MATLAB re-train 
with new images for each new training session. Then, image augmentation was 
utilized to randomly rotate and reflect the images to prevent overfitting and 
memorization of image features due to the small size of the image dataset.  
 
2.3 Neural Network Design 
   A CNN was developed to classify fundus images into 3 classes. This network 
consists of a 2D convolution layer, batch normalization layer, rectified linear unit 
(ReLU) layer, max pooling layer, fully connected layer, softmax layer, and 
classification layer (Figure 3).  
Figure 3 – Neural network schematic. 
First, a 2D convolution layer was deployed, consisting of 5 filters with a stride 
(step size in which the filter moves) of 1, which convolved the input layer by applying 
sliding filters horizontally and vertically. Given that the input pixel value of each 
fundus image examined is x(a,b,c), the output of the convolutional layer is y(w,y,z) -  
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which represents the feature maps extracted by convolving x(a,b,c) with f(w,a,b,c) - is 
specified as follows: 




𝑎=1 + 𝑏(𝑤)         (1) 
 
w represents the filter index where w = 1,2,3,4, 5. Similarly, m = 1,2,3,4…q and n = 
1,2,3,4…q where q represents the input dimension of the image. The terms b(w) and 
f(w,a,b,c) represent the biases and weights of the filters, respectively [20]. Due to the 
small dataset and to avoid underfitting, the bias values and weights were kept at default 
values. The weights were initialized with the Glorot initializer, which is optimal for 
neural networks with a single hidden layer, with a small Gaussian value with zero mean 
and variance = 2/(fan-in + fan-out) where fan-in = filterSize1× filterSize2 × Number of 
Input Channels and fan-out = filterSize1× filterSize2 × Number of Hidden Channels. The 
bias values were initialized with zeros since symmetry-breaking is provided through the 
weights. The number of neurons in a convolution layer is equivalent to the Map Size × 
Number of Filters. For example, if the input image is 32-by-32-by-3 the map size would 
be 15-by-15 since (32-5+(1×1))/2 +1 ≈ 15. The Map Size is then multiplied by the 
Number of Filters resulting in the total number of neurons being 15 × 15 × 5 = 1125. 
After the output was obtained, a batch normalization layer was included after each 
convolution layer, normalizing the input and speeding up training while reducing the 
sensitivity to network initialization. As shown in equation (2), the layer functions by 
calculating the normalized activations by using the mean μB and σ
2
B over the input 
channel and the mini batch. If the variance is very small, the ε property comes into play 




                                                                                                                                                                                                         (2)
   
The batch normalization layer was then followed by the rectified linear unit (ReLU) 
layer. This layer sets any value less than zero to zero; a type of threshold operation 
equivalent to equation (3) [22]. 
                                          (3) 
 
A max pooling layer was implemented to perform down sampling by separating 
the input into “rectangular pooling regions and computing the maximum of each region”; 
specifically, a pooling layer with 2 filters and a stride of 2 [23]. Next, the fully connected 
layer was deployed to acquire sub-feature maps to help classify them into three classes. 
The outputSize was set to 3 which represented the three classes: mild, severe, and high 
risk. The fully connected layer functioned by multiplying the input by a weight matrix 
and then adding a bias to that matrix as shown in equation (4) [24] [25] [26]: 




𝑘=1           (4) 
 
The terms ?̅?(𝑙, 𝑚, 𝑛) and ?̅?(𝑡) represent the weights and bias; t is the index where t = 1, 
2, and 3. As mentioned before, no bias values or weights were specified to avoid 
underfitting. Following the fully connected layer was the softmax function, which 
calculates the probability distribution. The softmax function is also known as the 





P(dr |y, θ) =   
         P( y,θ | dr )P(dr)








          (5) 
 
The limits for the probability, P(dr |y, θ), are from 0 to 1 and the term ∑  𝑃( 𝑑𝑗 | 𝑦, 𝜃)
𝑚
𝑖=1  is 
equal to 1. Additionally, br = ln(𝑃( 𝑦, 𝜃 | 𝑑𝑟  )𝑃(𝑑𝑟)) where 𝑃( 𝑦, 𝜃 | 𝑑𝑟  ) is the conditional 
probability of the sample class r and the prior probability P(dr) [27] . To successfully 
classify each fundus image, the cross-entropy loss was calculated in the final layer called 
the classification layer. The cross-entropy loss is defined as such: 
 




𝑗=1                (6) 
 
H is the number of classes, M is the number of samples, sji is the indicator that 
correlates the jth sample to the ith class, and uji is the output of the softmax function, 
associating the jth input with the ith class [27]. 
 
2.4 Simulation Options 
 Once the neural network was designed, the simulation options were specified. 
The learn rate of 0.01 was specified along with the maximum number of epochs of 
100 and a mini-batch size of 48. For network training, 52 randomly selected images 
were used. The remaining images (10) were used for classification. The command 
shuffle every-epoch was used to shuffle the training data before each epoch and also to 
take advantage of the batch normalization effect, thus making the training of the 
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neural network an effortless optimization problem. The algorithm used for training is 
the stochastic gradient descent with momentum (SGDM), which is defined as 
                   θn+1 = θn - β∇F(θn) + η(θn – θn-1)                            (7) 
where θ is the parameter vector n is the iteration number, β is the learn rate (β>0), 
η(θn– θn-1) is the momentum term/parameter, and F(θ) is the loss function. This 
SGDM algorithm minimizes the cross-entropy loss across the mini-batch by 
proceeding incrementally at each iteration in the direction of the gradient loss. Adding 
the momentum term, value of 0.9, helps reduce oscillations along the path of steep 








The neural network was simulated for a total of 25 times with 5 trials for each 
image size: 32×32, 64×64, 128×128, 256×256, and 512×512. The average 
simulation/processing time ranged from 25 seconds for 32×32 images, to 22 minutes for 
512×512 images. A confusion matrix was created for each of the image sizes to obtain 
statistical measures of performance, such as sensitivity, false negative rate, precision, and 
the false discovery rate. The sensitivity was 70% for 32×32 images, 65% for 64×64 
images, 60% for 128×128 images, 50% for 256×256 images and 50% for 512×512 
images. The sensitivity decreased as the size of the images increased; the opposite is true 
for the false negative rate. Similarly, the precision was 65% for 32×32 images, 65% for 
64×64 images, 60% for 128×128 images, 50% for 256×256 images, and 50% for 
512×512 images. The precision decreased as the size of the images increased, while the 
false discovery rate increased as the size of the images increased (Appendix II). These 
statistical measures suggest that a combination of a small image dataset and uneven 
classes may contribute to an increase in type I and type II errors thus leading to irrelevant 
results. The classification accuracy of the training and the test sets was determined by 
adding the number of correctly classified images divided by the total number of classified 
images; 52 images total for training and 10 images total for testing. As shown in Table 1, 
the training accuracy for the 32×32, 64×64, and 128×128 images ranged from 92% to 
97%. For both the 256×256 and 512×512 images, the training accuracy was 46%.  The 
training accuracy represents the accuracy of the neural network model on the image sets 
on which it was constructed. While within 100 epochs, most of the images up to size of 
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128×128 approached >90% training accuracy, the images of sizes 256×256 and 512×512 
had their respective training accuracy plateau at 46% with the 45th iteration (or epoch). 
 
Table 1 – Average classification accuracy of training and test images for 5 trials 
Image Sizes Avg. Training Accuracy (%) Avg. Test Accuracy (%) 
32×32 92.692 50.000 
64×64 97.307 48.000 
128×128 96.923 52.000 
256×256 46.153 50.000 
512×512 46.538 50.000 
 
The plateauing of the accuracy is significant because it means that the algorithm has hit 
convergence, where further training is likely to degrade the test accuracy and the training 
accuracy and result in overfitting. The test accuracy is the accuracy of the images the 
model has yet to see. Although the test accuracy of all the images was around 50%, an 
important observation to note is that the test accuracy did not improve as the image size 
increased, as one would intuitively believe since larger images have more pixel data. This 
shows, as is commonly known in the ophthalmologic field, that the majority (~90%) of 
cases, the information for proper diagnosis is around the optic nerve and macula region of 
the eye. Moreover, this suggests that different ROIs do not impact the diagnosis of DR.  
 
3.2 Validation 
 While the accuracy results were not ideal, they provide some insight into why 
they are low. Noticing the discrepancy between training accuracy and test accuracy, one 
would think that overfitting might be the reason. So, to test this hypothesis and to verify 
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the results, two methods were used: image normalization and transfer learning. 
  Image normalization is the process of changing the histogram values of an image 
to bring it to a range of intensity values that is “normal” (normal distribution). This 
avoids the influence of very low and very high noise in the image. In machine learning, 
image normalization is sometimes used to make learning more stable and to make the 
neural network generalize favorably to unseen data by reducing the variability between 
the training set and the testing set [18]. For this simulation, all images were normalized 
by taking each individual color channel and dividing them by the magnitude of all three 
(RGB) color channels (Figure 4).  
 
 
Figure 4 – Normalized fundus image. 
 
 
After normalization, the images were trained and tested using the CNN algorithm and 




Table 2 – Average classification accuracy of normalized images for 5 trials 
Image Sizes Avg. Training Accuracy (%) Avg. Test Accuracy (%) 
32×32 88.461 50.000 
64×64 96.153 50.000 
128×128 94.423 50.000 
256×256 46.153 50.000 
512×512 46.153 50.000 
 
The results show a similar pattern to the original results where the training accuracy is 
relatively high for image sizes of 32×32, 64×64, and 128×128 followed by a steep 
decrease to 46% for image sizes of 256×256 and 512×512. The test accuracy did not 
show a significant difference from the original results, staying around 50%. Two things 
that can be concluded from this method is that overfitting is not a cause for the 
discrepancy in the accuracy values and that the varied levels of lighting in the original 
images, which could possibly affect pixel intensity values and create unnecessary 
variation, did not impact the test accuracy.  
 Transfer learning utilizes a model that has been trained on a larger dataset which 
can be fine-tuned for a new task or new dataset; especially small datasets (<1000 
images). Compared to the performance of a model that is trained from scratch, it achieves 
higher network performance in a short amount of time. The pre-trained model used for 
transfer learning for this study is called AlexNet. This model was developed by Alex 
Krizhevsky utilizing the CNN algorithm. It has been trained on 1.2 million images from 
the ImageNet Dataset (http://image-net.org/index) with image dimensions of 227×227. 
The structure of the model consists of 5 convolution layers which together with the 
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remaining layers add to a total of 23 [29]. Once the model is selected, the last 
classification layer is replaced for a new classification task. Since an image size of 
227×227 is required as the input, fundus images with dimensions of 256×256 and 
512×512 were used by utilizing the function augmentedImageDatastore to automatically 
resize the images with no loss of data. Then, the model was simulated, and the training 
accuracy and test accuracy were obtained. Similar to the results of the normalized images 
and the original results, after 5 trials the average test accuracy was found to be 50%. On 
the other hand, the training accuracy was 100%. The high training accuracy is most likely 
due to overfitting since the transfer learning model did not include an image 
augmentation step to account for overfitting. While the use of transfer learning to 
improve classification of DR has been done using AlexNet [30], in this case transfer 
learning showed no significant improvement compared to the original method that was 
done from scratch. This strongly suggests that any additional convolution layers are 
unnecessary since the algorithm has already extracted all the features with one 
convolution layer for successful classification.  
3.3 Limitations 
The reason that neither the original method nor the validation methods were able 
to achieve greater than 50% accuracy can be attributed to one of many reasons which are 
also the limitations of this study. One limitation, perhaps the most impactful limitation, 
was the small amount of data available. While researchers have been able to use a small 
dataset to detect DR from 140 OCT images with a classification accuracy of 93%, no 
current literature exists demonstrating this with ultra-widefield fundus images. One could 
argue that with a more complex algorithm, i.e. with additional convolution layers, one 
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could achieve better performance [18]. However, as stated previously that even with 
additional layers, the algorithm showed no improvement in performance.  
Another limitation was the unbalanced image classes caused by a lack of diseased 
images. Initially, the images were rearranged into four classes where the classification 
accuracy (test accuracy) was found to be 35%. With the images rearranged into 2 classes, 
the classification accuracy was 60% (see Appendix III for probability values). Although 
decreasing the number of classes does increase accuracy, it is not beneficial for doctors 
since they would need to further examine the fundus images to determine the best 
treatment plan. Other ways to tackle the unbalanced image classes were to balance the 
classes by removing images from larger classes or by adjusting weights and bias 
components in the algorithm. By having an equal number of images in each of the three 
classes, the training accuracy decreased to around 80% for most of the image sizes and 
the test accuracy decreased for three of the image sizes ranging from 28% to 39% 
(Appendix I). There were additional trials done by adjusting the weights to “zeros” and 
changing the bias to “ones”. The average classification accuracy for all images was about 
23% thus severely underfitting and resulting in high training loss; neither able to model 
the training images nor able to generalize the test images. 
A third limitation in this study was the presence of unnecessary features such as 
eyelashes (Figure 5) and camera artifacts (Figure 6) in some of the images. The presence 
of eyelashes caused the CNN algorithm to learn the unnecessary features and thus 
































The goals of this study were to develop an algorithm to classify ultra-widefield 
fundus images into one of the 3 major classes of diabetic retinopathy, evaluate and 
compare the accuracy of the classification between different areas and sizes of fundus 
images, and explore the limitations of using CNN for ultra-widefield images. 
Validation methods such as image normalization and transfer learning were also done 
to calculate the classification accuracy and justify the algorithm that was developed 
from scratch. While the results are not ideal, they demonstrate the potential for 
applying deep learning algorithms to ultra-widefield images and the need for doctors 
to further examine the diagnosis to account for false positives and/or misdiagnosis.  
Future work in this subject would include improvements to the CNN algorithm 
as more images are obtained in order to improve the classification accuracy. 
Additional research would be done to determine if the file type of an image (e.g. JPEG 
or TIF) impacts the classification accuracy. Also, instead of concentric circles which 
mainly focus on the optic nerve, different sections of an image may be isolated/cut out 
where the accuracy of different regions of the eye may be compared to see if the 
classification accuracy solely relies on the optic nerve. Lastly, some pre-processing 
would be done to remove artifacts such as eyelashes from the images to reduce the 
number of features to be learned by the CNN algorithm; only if the flexibility is 
available to do so i.e. large amount of data available where removal of some images 
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2 0.6667 0.6000 
3 0.5995 0.6000 
4 0.5789 0.6000 
5 0.6140 0.4000 




2 0.6140 0.4000 
3 0.7719 0.2000 
4 0.6140 0.4000 
5 0.8421 0.4000 




2 0.7018 0.2000 
3 0.7719 0.6000 
4 0.7576 0.4000 
5 0.9394 0.4828 




2 0.6061 0.3793 
3 0.9394 0.1724 
4 0.6970 0.2069 
5 0.9394 0.3448 




2 0.9091 0.3103 
3 0.8596 0.6000 
4 0.6667 0.8000 
5 0.8741 0.6333 






















2 0.9615 0.7000 
3 0.9038 0.4000 
4 0.9423 0.3000 
5 0.9230 0.5000 




2 0.9807 0.5000 
3 0.9807 0.6000 
4 0.9615 0.5000 
5 0.9423 0.4000 




2 0.9615 0.5000 
3 1.0000 0.4000 
4 0.9807 0.5000 
5 1.0000 0.6000 




2 0.4615 0.5000 
3 0.4615 0.5000 
4 0.4615 0.5000 
5 0.4615 0.5000 




2 0.4615 0.5000 
3 0.4615 0.5000 
4 0.4615 0.5000 
5 0.4615 0.5000 
  Avg. (%) 46.538 50.000 
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APPENDIX II – Confusion Matrices 
 
Far right column = precision, false discovery rate 
 
Bottom row = sensitivity, miss rate 
 





































APPENDIX III – Probability Data  
 








10001418 OS abnormal 0.99998534 1.47E-05 
10022953 OS abnormal 2.43E-07 0.99999976 
10029705-20180416@112408-L4 abnormal 0.99998879 1.12E-05 
10029705-20180416@112408-R3 abnormal 0.13589142 0.86410856 
10041101 OD abnormal 0.005335684 0.99466431 
10041101 OS abnormal 3.72E-08 1 
10046318 OS abnormal 0.14558524 0.85441476 
10055620 OD abnormal 0.99221849 0.007781468 
10055620 OS abnormal 0.00250658 0.99749339 
10065949 OS abnormal 0.0087861 0.99121398 
10068165 OD abnormal 0.040095784 0.95990425 
10075046 OD abnormal 0.80176336 0.19823663 
10075046 OS abnormal 0.80258894 0.19741113 
10077406 OD abnormal 0.66958404 0.33041599 
10077406 OS abnormal 0.99926466 0.000735337 
10084968 OS abnormal 0.16454743 0.83545256 
10086708 OS abnormal 6.59E-10 1 
10117924-20180220@102014-L4 abnormal 0.79679787 0.20320213 
10145754-20180415@105849-L2 abnormal 0.99968874 0.000311262 
10145754-20180415@105849-R1 abnormal 0.99999964 3.16E-07 
10148705-20180425@100700-R3 abnormal 0.9999944 5.65E-06 
10149811-20180225@090046-R1 abnormal 0.99999905 9.38E-07 
10158969-20180506@090506-R1 abnormal 0.99999976 2.90E-07 
10001091 OD abnormal 0.38385868 0.61614132 
10001091 OS abnormal 0.23049685 0.76950318 
10000464 OS mild/moderate 2.74E-09 1 
10000484 OD mild/moderate 0.9986406 0.001359399 
10001418 OD mild/moderate 0.99864513 0.001354832 
10004898 OS mild/moderate 4.69E-15 1 
10008285 OS mild/moderate 0.73723733 0.26276267 
10013404 OD mild/moderate 0.96721429 0.032785717 
10018169 OD mild/moderate 0.96985573 0.03014431 
10022953 OD mild/moderate 0.026244124 0.9737559 
10022979-20180213@155058-R1 mild/moderate 0.99999571 4.26E-06 
10025329 OD mild/moderate 0.99999142 8.55E-06 
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10028832 OD mild/moderate 0.99961448 0.000385448 
10028832 OS mild/moderate 3.78E-06 0.99999619 
10037058 OD mild/moderate 0.44739011 0.55260986 
10037058 OS mild/moderate 0.1597831 0.84021693 
10041971 OD mild/moderate 0.048188951 0.95181108 
10041971 OS mild/moderate 5.42E-10 1 
10047851 mild/moderate 0.5488714 0.45112863 
10047851 OD mild/moderate 0.99706465 0.002935403 
10051334 OD mild/moderate 8.39E-06 0.99999166 
10051334 OS mild/moderate 0.018040443 0.98195964 
10059609-20180325@094033-L3 mild/moderate 0.090828925 0.9091711 
10065949 OD mild/moderate 0.99982738 0.000172549 
10068165 OS mild/moderate 1.01E-05 0.99998987 
10072783-20180121@092503-L2 mild/moderate 0.97144598 0.028554037 
10075925 OD mild/moderate 0.99999118 8.78E-06 
10081192 OS mild/moderate 8.48E-06 0.99999154 
10084968 OD mild/moderate 0.01174185 0.98825818 
10086708 OD mild/moderate 0.000257731 0.99974221 
10088791 OD mild/moderate 1 2.72E-23 
10088791 OS mild/moderate 1.82E-05 0.99998188 
10093928 OS mild/moderate 1.98E-07 0.99999976 
10117924-20180220@102014-R2 mild/moderate 0.99999177 8.24E-06 
10131726-20180319@085722-L3 mild/moderate 0.007010281 0.99298966 
10131726-20180319@085722-R2 mild/moderate 0.99999964 3.62E-07 
10158969-20180506@090506-L2 mild/moderate 0.99999547 4.52E-06 
10166525-20180402@083736-L4 mild/moderate 0.8872788 0.11272123 
10167812-20180424@134719-L2 mild/moderate 0.05154828 0.94845176 









10001418 OS abnormal 1 1.64E-09 
10022953 OS abnormal 1 8.43E-10 
10029705-20180416@112408-L4 abnormal 1 8.60E-09 
10029705-20180416@112408-R3 abnormal 0.99998713 1.29E-05 
10041101 OD abnormal 1 8.74E-11 
10041101 OS abnormal 1 1.68E-32 
10046318 OS abnormal 1 1.55E-21 
10055620 OD abnormal 1 1.93E-20 
10055620 OS abnormal 1 2.76E-22 
10065949 OS abnormal 0.99999964 3.26E-07 
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10068165 OD abnormal 0.99998391 1.62E-05 
10075046 OD abnormal 0.99999857 1.49E-06 
10075046 OS abnormal 1 4.30E-18 
10077406 OD abnormal 1 1.64E-12 
10077406 OS abnormal 0.99997497 2.51E-05 
10084968 OS abnormal 1 2.28E-14 
10086708 OS abnormal 1 2.85E-15 
10117924-20180220@102014-L4 abnormal 0.99986422 1.36E-04 
10145754-20180415@105849-L2 abnormal 0.99998403 1.60E-05 
10145754-20180415@105849-R1 abnormal 1 8.69E-10 
10148705-20180425@100700-R3 abnormal 1.85839E-15 1.00E+00 
10149811-20180225@090046-R1 abnormal 1 6.47E-14 
10158969-20180506@090506-R1 abnormal 0.99999356 6.40E-06 
10001091 OD abnormal 1 8.70E-14 
10001091 OS abnormal 1 4.15E-21 
10000464 OS mild/moderate 1.58362E-24 1.00E+00 
10000484 OD mild/moderate 1.956E-08 1.00E+00 
10001418 OD mild/moderate 5.52701E-09 1.00E+00 
10004898 OS mild/moderate 1.45156E-40 1.00E+00 
10008285 OS mild/moderate 0.06106123 0.9389388 
10013404 OD mild/moderate 1.74044E-10 1 
10018169 OD mild/moderate 2.02048E-09 1 
10022953 OD mild/moderate 1.57295E-14 1 
10022979-20180213@155058-R1 mild/moderate 1.11E-06 0.99999893 
10025329 OD mild/moderate 4.45E-11 1 
10028832 OD mild/moderate 1.11E-06 0.99999893 
10028832 OS mild/moderate 2.92E-06 0.99999714 
10037058 OD mild/moderate 1.01E-12 1 
10037058 OS mild/moderate 1.00E+00 1.16596E-11 
10041971 OD mild/moderate 9.82E-01 0.017991316 
10041971 OS mild/moderate 1.79E-08 1 
10047851 mild/moderate 2.03E-10 1 
10047851 OD mild/moderate 4.06E-09 1 
10051334 OD mild/moderate 1.91E-23 1 
10051334 OS mild/moderate 3.85E-06 0.99999619 
10059609-20180325@094033-L3 mild/moderate 1.00E+00 3.93148E-06 
10065949 OD mild/moderate 8.95E-06 0.99999106 
10068165 OS mild/moderate 1.65E-05 0.99998355 
10072783-20180121@092503-L2 mild/moderate 1.07E-05 0.99998927 
10075925 OD mild/moderate 1.13E-08 1 
10081192 OS mild/moderate 2.30E-11 1 
10084968 OD mild/moderate 4.49E-13 1 
10086708 OD mild/moderate 1.62E-11 1 
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10088791 OD mild/moderate 2.49E-05 0.99997509 
10088791 OS mild/moderate 0.00E+00 1 
10093928 OS mild/moderate 4.34E-07 0.99999952 
10117924-20180220@102014-R2 mild/moderate 5.35E-11 1 
10131726-20180319@085722-L3 mild/moderate 4.32E-07 0.99999952 
10131726-20180319@085722-R2 mild/moderate 2.71E-11 1 
10158969-20180506@090506-L2 mild/moderate 2.51E-05 0.99997485 
10166525-20180402@083736-L4 mild/moderate 1.07E-05 0.99998927 
10167812-20180424@134719-L2 mild/moderate 1.01E-07 0.99999988 









10001418 OS abnormal 0.99999952 4.87E-07 
10022953 OS abnormal 0.99995208 4.79E-05 
10029705-20180416@112408-L4 abnormal 0.99989486 1.05E-04 
10029705-20180416@112408-R3 abnormal 0.99989188 0.000108118 
10041101 OD abnormal 0.99984419 0.000155748 
10041101 OS abnormal 1 6.96896E-11 
10046318 OS abnormal 0.99984348 1.56E-04 
10055620 OD abnormal 1 8.19795E-10 
10055620 OS abnormal 0.9999969 3.10E-06 
10065949 OS abnormal 0.99955744 0.000442587 
10068165 OD abnormal 0.99990392 9.60951E-05 
10075046 OD abnormal 0.99993837 6.16E-05 
10075046 OS abnormal 0.99998069 1.92567E-05 
10077406 OD abnormal 0.9999969 3.14E-06 
10077406 OS abnormal 0.99981743 0.000182557 
10084968 OS abnormal 0.99996579 3.43E-05 
10086708 OS abnormal 0.99994266 5.73716E-05 
10117924-20180220@102014-L4 abnormal 0.99999535 4.61176E-06 
10145754-20180415@105849-L2 abnormal 0.9999938 6.17E-06 
10145754-20180415@105849-R1 abnormal 0.9999516 4.84E-05 
10148705-20180425@100700-R3 abnormal 0.9998908 0.000109201 
10149811-20180225@090046-R1 abnormal 0.99998224 1.77666E-05 
10158969-20180506@090506-R1 abnormal 0.99998629 1.37E-05 
10001091 OD abnormal 0.99988723 1.13E-04 
10001091 OS abnormal 0.99999547 4.55215E-06 
10000464 OS mild/moderate 4.67553E-06 0.99999535 
10000484 OD mild/moderate 0.000164147 1.00E+00 
33 
 
10001418 OD mild/moderate 1.82634E-05 1.00E+00 
10004898 OS mild/moderate 3.41719E-12 1.00E+00 
10008285 OS mild/moderate 1.72229E-06 0.99999833 
10013404 OD mild/moderate 5.08921E-05 0.9999491 
10018169 OD mild/moderate 0.000141378 0.99985862 
10022953 OD mild/moderate 6.75234E-05 0.99993253 
10022979-20180213@155058-R1 mild/moderate 1.48E-04 0.99985194 
10025329 OD mild/moderate 1.44E-01 0.8564226 
10028832 OD mild/moderate 8.03106E-06 0.99999201 
10028832 OS mild/moderate 7.74E-02 0.92256796 
10037058 OD mild/moderate 2.03E-08 1 
10037058 OS mild/moderate 0.000249152 0.99975079 
10041971 OD mild/moderate 4.99E-05 0.99995017 
10041971 OS mild/moderate 8.07E-05 0.9999193 
10047851 mild/moderate 0.99851722 0.001482814 
10047851 OD mild/moderate 1.63E-04 0.99983692 
10051334 OD mild/moderate 4.39E-05 0.99995601 
10051334 OS mild/moderate 0.000212336 0.99978763 
10059609-20180325@094033-L3 mild/moderate 3.41E-05 0.99996591 
10065949 OD mild/moderate 1.00E+00 5.6119E-05 
10068165 OS mild/moderate 0.88677871 0.11322127 
10072783-20180121@092503-L2 mild/moderate 0.000187775 0.9998123 
10075925 OD mild/moderate 0.000161167 0.99983883 
10081192 OS mild/moderate 1.24959E-06 0.99999881 
10084968 OD mild/moderate 1.11E-05 0.99998891 
10086708 OD mild/moderate 6.08E-07 0.9999994 
10088791 OD mild/moderate 1.00E+00 5.53622E-09 
10088791 OS mild/moderate 2.88794E-05 0.99997115 
10093928 OS mild/moderate 1.25E-04 0.99987519 
10117924-20180220@102014-R2 mild/moderate 0.22493188 0.7750681 
10131726-20180319@085722-L3 mild/moderate 1.88E-04 0.99981159 
10131726-20180319@085722-R2 mild/moderate 2.67E-10 1 
10158969-20180506@090506-L2 mild/moderate 0.9999944 5.60941E-06 
10166525-20180402@083736-L4 mild/moderate 0.99999702 3.02197E-06 
10167812-20180424@134719-L2 mild/moderate 9.99E-01 0.000615534 










10001418 OS abnormal 1 9.18E-11 
10022953 OS abnormal 0.99997783 2.22E-05 
10029705-20180416@112408-L4 abnormal 0.99998868 1.14E-05 
10029705-20180416@112408-R3 abnormal 0.99999261 7.3702E-06 
10041101 OD abnormal 0.99998462 1.53752E-05 
10041101 OS abnormal 1 1.09164E-08 
10046318 OS abnormal 0.99999988 9.78637E-08 
10055620 OD abnormal 1 2.52E-11 
10055620 OS abnormal 0.99998379 1.63E-05 
10065949 OS abnormal 0.99996638 3.36E-05 
10068165 OD abnormal 0.99999881 1.25081E-06 
10075046 OD abnormal 0.99996507 3.49861E-05 
10075046 OS abnormal 0.99999797 2.01E-06 
10077406 OD abnormal 0.99999964 3.7115E-07 
10077406 OS abnormal 0.99999583 4.12848E-06 
10084968 OS abnormal 0.99999988 1.14369E-07 
10086708 OS abnormal 1 3.93208E-10 
10117924-20180220@102014-L4 abnormal 1 3.17E-13 
10145754-20180415@105849-L2 abnormal 1 2.96E-08 
10145754-20180415@105849-R1 abnormal 1 4.2894E-15 
10148705-20180425@100700-R3 abnormal 0.99994671 5.32E-05 
10149811-20180225@090046-R1 abnormal 0.99999869 1.30E-06 
10158969-20180506@090506-R1 abnormal 0.9999795 2.05E-05 
10001091 OD abnormal 0.99997497 2.51E-05 
10001091 OS abnormal 1 9.43E-15 
10000464 OS mild/moderate 1.80009E-07 1.00E+00 
10000484 OD mild/moderate 0.9988721 0.001127839 
10001418 OD mild/moderate 9.05139E-09 1.00E+00 
10004898 OS mild/moderate 5.21877E-11 1.00E+00 
10008285 OS mild/moderate 0.58756328 0.41243672 
10013404 OD mild/moderate 9.22898E-05 0.99990773 
10018169 OD mild/moderate 0.99998701 1.29961E-05 
10022953 OD mild/moderate 1.32348E-05 0.99998677 
10022979-20180213@155058-R1 mild/moderate 2.89E-05 0.99997103 
10025329 OD mild/moderate 5.43E-09 1 
10028832 OD mild/moderate 0.028293183 0.97170681 
10028832 OS mild/moderate 9.00074E-09 1 
10037058 OD mild/moderate 3.18E-14 1 
10037058 OS mild/moderate 6.41E-15 1 
10041971 OD mild/moderate 7.89E-06 0.99999213 
10041971 OS mild/moderate 2.33375E-07 0.99999976 
10047851 mild/moderate 7.12E-03 0.99288416 
10047851 OD mild/moderate 3.11E-05 0.99996889 
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10051334 OD mild/moderate 8.69E-06 0.9999913 
10051334 OS mild/moderate 2.20107E-09 1 
10059609-20180325@094033-L3 mild/moderate 1.88E-10 1 
10065949 OD mild/moderate 4.30446E-05 0.99995697 
10068165 OS mild/moderate 0.99974483 0.000255199 
10072783-20180121@092503-L2 mild/moderate 4.13E-05 0.99995875 
10075925 OD mild/moderate 9.99E-01 0.000701777 
10081192 OS mild/moderate 3.14926E-05 0.99996853 
10084968 OD mild/moderate 3.49794E-13 1.00E+00 
10086708 OD mild/moderate 1.06E-06 0.99999893 
10088791 OD mild/moderate 1.19E-21 1 
10088791 OS mild/moderate 9.07903E-06 0.99999094 
10093928 OS mild/moderate 9.8197E-07 0.99999905 
10117924-20180220@102014-R2 mild/moderate 0.99951839 0.000481647 
10131726-20180319@085722-L3 mild/moderate 9.93E-10 1 
10131726-20180319@085722-R2 mild/moderate 2.40E-18 1 
10158969-20180506@090506-L2 mild/moderate 9.26337E-06 0.9999907 
10166525-20180402@083736-L4 mild/moderate 3.21697E-05 0.99996781 
10167812-20180424@134719-L2 mild/moderate 9.34E-06 0.9999907 








10001418 OS abnormal 0.99936146 0.000638496 
10022953 OS abnormal 0.9960413 0.003958674 
10029705-20180416@112408-L4 abnormal 0.99952638 4.74E-04 
10029705-20180416@112408-R3 abnormal 0.99940002 6.00E-04 
10041101 OD abnormal 0.97922426 0.020775726 
10041101 OS abnormal 0.98724443 0.01275562 
10046318 OS abnormal 0.92326951 0.07673049 
10055620 OD abnormal 0.9999845 1.55044E-05 
10055620 OS abnormal 0.9982987 1.70E-03 
10065949 OS abnormal 0.003065838 0.99693418 
10068165 OD abnormal 0.97903001 0.020969966 
10075046 OD abnormal 0.96919304 0.030806985 
10075046 OS abnormal 0.034994565 0.96500546 
10077406 OD abnormal 0.96866268 0.031337354 
10077406 OS abnormal 1.77919E-07 0.99999988 
10084968 OS abnormal 0.9262225 0.073777564 
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10086708 OS abnormal 0.004060022 0.99593997 
10117924-20180220@102014-L4 abnormal 0.999982 1.7998E-05 
10145754-20180415@105849-L2 abnormal 0.99996924 3.07769E-05 
10145754-20180415@105849-R1 abnormal 0.99999881 1.21834E-06 
10148705-20180425@100700-R3 abnormal 0.99959844 0.00040161 
10149811-20180225@090046-R1 abnormal 0.97366387 0.026336132 
10158969-20180506@090506-R1 abnormal 0.99999619 3.78E-06 
10001091 OD abnormal 0.96762341 0.032376532 
10001091 OS abnormal 0.99683553 3.16E-03 
10000464 OS mild/moderate 6.08433E-06 0.99999392 
10000484 OD mild/moderate 0.01140972 0.9885903 
10001418 OD mild/moderate 0.084231965 0.91576803 
10004898 OS mild/moderate 0.000502195 0.99949777 
10008285 OS mild/moderate 0.005196332 0.99480361 
10013404 OD mild/moderate 0.15164208 0.84835792 
10018169 OD mild/moderate 0.000914671 0.99908531 
10022953 OD mild/moderate 0.046061426 0.9539386 
10022979-20180213@155058-R1 mild/moderate 6.56536E-06 0.99999344 
10025329 OD mild/moderate 2.68299E-08 1 
10028832 OD mild/moderate 1.29917E-05 0.99998701 
10028832 OS mild/moderate 0.001329623 0.99867034 
10037058 OD mild/moderate 6.37248E-08 0.99999988 
10037058 OS mild/moderate 4.54236E-09 1 
10041971 OD mild/moderate 0.72162044 0.27837956 
10041971 OS mild/moderate 0.000409728 0.99959034 
10047851 mild/moderate 0.027813982 0.97218597 
10047851 OD mild/moderate 0.062140908 0.93785918 
10051334 OD mild/moderate 0.16369528 0.83630472 
10051334 OS mild/moderate 0.001955796 0.99804413 
10059609-20180325@094033-L3 mild/moderate 1.27724E-08 1 
10065949 OD mild/moderate 0.53620446 0.46379557 
10068165 OS mild/moderate 0.001630107 0.99836987 
10072783-20180121@092503-L2 mild/moderate 0.004932033 0.99506795 
10075925 OD mild/moderate 0.10453955 0.89546043 
10081192 OS mild/moderate 0.010845487 0.98915452 
10084968 OD mild/moderate 0.33051535 0.66948467 
10086708 OD mild/moderate 0.000114546 0.99988544 
10088791 OD mild/moderate 0.68852872 0.31147122 
10088791 OS mild/moderate 7.09177E-07 0.99999928 
10093928 OS mild/moderate 0.001435881 0.99856418 
10117924-20180220@102014-R2 mild/moderate 0.000862961 0.9991371 
10131726-20180319@085722-L3 mild/moderate 0.004823742 0.9951762 
10131726-20180319@085722-R2 mild/moderate 0.000321771 0.99967825 
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10158969-20180506@090506-L2 mild/moderate 0.091181904 0.90881807 
10166525-20180402@083736-L4 mild/moderate 0.11425235 0.88574767 
10167812-20180424@134719-L2 mild/moderate 0.027037384 0.97296256 
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